Provided by Tiger Trade Technology Pte. Ltd.

InspireMD

0.6678
-0.0259-3.74%
Post-market: 0.68000.0122+1.83%19:02 EDT
Volume:178.04K
Turnover:119.33K
Market Cap:31.05M
PE:-1.03
High:0.7100
Open:0.7048
Low:0.6101
Close:0.6938
52wk High:2.57
52wk Low:0.6000
Shares:46.49M
Float Shares:34.07M
Volume Ratio:2.75
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6464
EPS(LYR):-0.7584
ROE:-202.81%
ROA:-85.85%
PB:0.99
PE(LYR):-0.88

Loading ...

InspireMD reports zero major adverse events at 30 days in CGUARDIANS II TCAR study of CGuard Prime 80 cm stent

Reuters
·
Jun 11

InspireMD - No Deaths, Strokes, or Myocardial Infarctions Reported Within 30 Days in Cguardians Ii

THOMSON REUTERS
·
Jun 11

InspireMD - Cguardians Ii Trial Achieves 100% Acute Device Success Rate

THOMSON REUTERS
·
Jun 11

InspireMD Inc: Anticipates Potential Approval of Cguard Prime 80 Cm Stent Implant in Second Half of This Year

THOMSON REUTERS
·
Jun 11

InspireMD Announces 30-Day Results From the Cguardians Ii Clinical Trial of the Cguard Prime 80 Cm Implant for Use in Tcar Procedures

THOMSON REUTERS
·
Jun 11

InspireMD Announces First Patient Enrolled in the Cguardians Iii Pivotal Study of the Switchguard Neuro Protection System for Use in Tcar Procedures

THOMSON REUTERS
·
Jun 08

InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures

GlobeNewswire
·
Jun 08

InspireMD Shareholders Approve Stock Increase and Board Slate

TIPRANKS
·
Jun 04

InspireMD shareholders approve increase in authorized common shares to 250 million

Reuters
·
Jun 04

InspireMD director Paul Stuka acquires 20,000 common shares valued at $17,500

Reuters
·
May 30

InspireMD chair Paul Stuka to retire, won’t seek board reelection in 2027

Reuters
·
May 23

Top InspireMD Executive Makes Notable Move With Latest Stock Sale

TIPRANKS
·
May 22

InspireMD director Paul Stuka buys USD 17,325 common shares

Reuters
·
May 16

Top Executive Makes Bold Move With Fresh InspireMD Stock Purchase

TIPRANKS
·
May 14

InspireMD CEO Marvin Slosman acquires 21,000 shares valued at $25,200

Reuters
·
May 14

InspireMD director Paul Stuka buys common shares worth $87,125.56

Reuters
·
May 13

InspireMD Balances Fast Growth With U.S. Setback

TIPRANKS
·
May 11

Insiders Make Bold Moves as InspireMD Directors Load Up on Shares

TIPRANKS
·
May 09

InspireMD director Scott R. Ward acquires common shares worth $102,125

Reuters
·
May 09

InspireMD director Paul Stuka acquires 7,895 shares worth $9,053.79

Reuters
·
May 09